ABT trade ideas
$ABT possible short with good Risk/Reward RatioLooking for a short trade on $ABT. Chart is self-explanatory (I hope). Wait for reversal clues between 66.5 and 67 levels before trading, since this is a counter-trend idea.
ABT breaks down channel- As predicted. if ABT successfully broke down channel (pink) it would head into new up channel
- Overall correction looks like its ended and now looking to hit previous high
ABT breaking out- ABT previously resisted in down channel (pink)
- Trend step long and MMAR fully reversed to long
- Weekly MACD coming off back end of short trend
- Wait for ABT to close above pink channel
possible longABT has come back into longterm daily uptrend. on the hourly chart this may be a double bottom and zooming out on the daily we are pretty close to the .618 retracement. Seeing slgiht rejection on the hourly so this may be good for a quick scalp
Bull flag forming in Abbott Labs $100 target on break.Upside target in the $100 region , earnings approaching in October could be the stimulus for that move.
ABT specialize in Diabetes, which is one of the fastest growing disease in the world, the potential growth for ABT in huge which is reflected in the increased hiring in its European bases.
As more of the world comes out of poverty, a unfortunate result is the rise in such diet related illnesses.
Company profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Daily ABT stock price trend forecasts analysis 15-JUL
Investing position: In Rising section of high profit & low risk so far. But it would be in falling section tomorrow
S&D strength Trend: In the midst of an adjustment trend of downward direction box pattern price flow marked by limited rises and downward fluctuations.
Today's S&D strength Flow: Supply-Demand(S&D) strength flow appropriate to the current trend.
read more: www.pretiming.com
Forecast D+1 Candlestick Color : RED Candlestick
%D+1 Range forecast: 0.1% (HIGH) ~ -0.7% (LOW), -0.3% (CLOSE)
%AVG in case of rising: 1.1% (HIGH) ~ -0.4% (LOW), 0.9% (CLOSE)
%AVG in case of falling: 0.5% (HIGH) ~ -1.1% (LOW), -0.5% (CLOSE)
Abbott Announces FDA Approval of the Alinity(TM) s SystemABT: Abbott
2019-07-11 09:00:00
Abbott Announces FDA Approval of the Alinity(TM) s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
ABT Long Clear uptrend channel with a bullish divergence on the RSI. A strong company with a variety of products coming to market.
$ABT ABBOTTS beats on earnings but we expect pullbackAbbotts quite simply does not miss earnings, a fantastic company and fantastic product in the ever increasing market of Diabetes treatment. Despite this we see a little stagnant price action lately and a pullback is quite possible.
ABT earnings name with interesting after-hour session! ABT is releasing earnings today , news that worth us to keep an eye on it. Volumes during after-hours session are above 500K and there is a beautiful pullback below the 50eMA forming a clean bear flag. We would have preferred an actual gap but in this case we are talking about a top name that could make anyway a move!! After-hours conditions unless price action will start to chop around in pre-market session are nice. Let's see how it will develop, possible 73.85 / 70.53 or just keeping pulling back to the 78? No BIAS just price action. Have a nice trade everyone!!
Abbott Receives FDA Approval for Expanded Indication for MitraClABT: Abbott
2019-03-14 13:52:00
Abbott Receives FDA Approval for Expanded Indication for MitraClip(TM) Device - PR Newswire
